SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001019687-16-004872
Filing Date
2016-01-19
Accepted
2016-01-19 17:30:43
Documents
51
Period of Report
2015-10-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 pharmacyte_10qa2-103115.htm 10-Q/A 362020
2 CERTIFICATION pharmacyte_ex3101.htm EX-31.1 7766
3 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 3813
  Complete submission text file 0001019687-16-004872.txt   2747659

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE pmcb-20151031.xml EX-101.INS 575897
5 XBRL SCHEMA FILE pmcb-20151031.xsd EX-101.SCH 25002
6 XBRL CALCULATION FILE pmcb-20151031_cal.xml EX-101.CAL 43690
7 XBRL DEFINITION FILE pmcb-20151031_def.xml EX-101.DEF 106348
8 XBRL LABEL FILE pmcb-20151031_lab.xml EX-101.LAB 197998
9 XBRL PRESENTATION FILE pmcb-20151031_pre.xml EX-101.PRE 183129
Mailing Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q/A | Act: 34 | File No.: 333-68008 | Film No.: 161349178
SIC: 2833 Medicinal Chemicals & Botanical Products